Insider Buying CSL Finance Chief Operating Officer Bought 12m Of Shares - Simply Wall St
| CSLLY Stock | USD 91.88 0.69 0.76% |
Slightly above 53% of CSL's investor base is interested to short. The analysis of overall sentiment of trading CSL pink sheet suggests that many investors are impartial at this time. CSL's investing sentiment can be driven by a variety of factors including economic data, CSL's earnings reports, geopolitical events, and overall market trends.
CSL |
Insider Buying CSL Finance Chief Operating Officer Bought 12m Of Shares Simply Wall St
Read at news.google.com
 |
CSL Fundamental Analysis
We analyze CSL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
CSL is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
CSL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CSL pink sheet to make a market-neutral strategy. Peer analysis of CSL could also be used in its relative valuation, which is a method of valuing CSL by comparing valuation metrics with similar companies.
Peers
CSL Related Equities
| ANTX | AN2 Therapeutics | 21.90 | ||||
| BGNE | BeiGene | 4.29 | ||||
| RAPT | RAPT Therapeutics | 2.44 | ||||
| SNDX | Syndax Pharmaceuticals | 1.27 | ||||
| VTYX | Ventyx Biosciences | 1.13 | ||||
| NONOF | Novo Nordisk | 0.23 | ||||
| NUVL | Nuvalent | 0.08 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| SLRN | ACELYRIN, INC | 0.44 | ||||
| CRBU | Caribou Biosciences | 0.45 | ||||
| COGT | Cogent Biosciences | 0.73 | ||||
| PEPG | PepGen | 0.98 | ||||
| KNSA | Kiniksa Pharmaceuticals | 1.08 | ||||
| KURA | Kura Oncology | 1.16 | ||||
| RVMD | Revolution Medicines | 1.25 | ||||
| PHVS | Pharvaris | 2.06 | ||||
| CMXHF | CSL | 2.11 | ||||
| MLYS | Mineralys Therapeutics, | 2.59 | ||||
| LRMR | Larimar Therapeutics | 4.67 |
Additional Tools for CSL Pink Sheet Analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.